Navigation Links
The End is Near or Is It?

s management to careful rebuilding and growth. And most triathletes know that its the transitions that can make or break the race. So whats a weary executive, one who has never trained for this event (hell, didnt even want to enter it), going to do?

Reset expectations now. First and foremost, begin thinking about the next six months not as the end of the economic recession, but as the beg......

Full article >>>
'"/>

Source:wistechnology.com By Chris Shipley 06/18/03


Page: 1 2 3 4

Related biology technology :

1. Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon Allelic Discrimination Kits
2. Genotyping Single Nucleotide Polymorphisms with Molecular Beacons
3. New Protocols for Isolating High- Molecular-Weight Genomic DNA
4. HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex Virus DNA
5. Molecular Biology:Easy Dephosphorylation and Rapid DNA Ligation
6. Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A
7. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
8. Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers
9. Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36)
10. Near Infrared Technology and Optical Agents For Molecular Imaging
11. The Molecular Organization

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The End Near

(Date:11/25/2009)... Ambassador to Speak at Economic Clu...nada (Vocus) November 25, 2009 -- Ambassador to Sp...id Appia, French Ambassador for International Inve...ce Agency ,To view a biography of David Appia go t...r Appia is available to meet with press to discuss...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/ -- ...nd provider of vaccines, announced today that it e...h Sinovac (Dalian) Vaccine,Technology Co., Ltd. (S...duce,and commercialize human-use vaccines. Sinovac...eveloping and commercializing world-class vaccines...
(Date:11/24/2009)...ease is available in German . , Whether it,...: RFID tags (Radio Frequency Identification) are i...They make it possible to label objects or goods an...The appropriate scanner can read and process the d...fixed to goods under production conditions of up t...
(Date:11/24/2009)... The New York investment bank KTA Ca...) has agreed an AU$6.7 mil convertible note privat...e private placement was arranged by KTA Capital as..., New York (PRWEB) Novembe...bank KTA Capital, LLC ("KTA Capital") ha...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...INCETON, N.J., Sept. 5 Medarex, Inc.,(Nasdaq: ME...body,development relationship with its licensing p...ip provides Centocor with continued access to Meda... for the generation of fully,human antibodies to a... the new agreement, Centocor will license Medarex,...
...EISING-WEIHENSTEPHAN, Germany, September 5 Pieris...lins(R), a novel class of,targeted human protein t...,of a series of preclinical studies validating the...The studies reported by Pieris relate to PRS-055, ...actor in the regulation of neovascular,permeabilit...
...Clinical benefit observed in over 60% of evaluable...s, Inc.,(Nasdaq: EXEL ) today reported interim da...as first-line therapy for patients with non-small ...trial is ongoing in previously,untreated patients ...a,histology and meet one of the following three cr...
Other Biology Technology:Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 3Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer 2Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer 3Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer 4
(Date:11/30/2009)... , A new research report published in the Decembe...e day give men similar type of control over their ...t,s because scientists have found how and where an...rmal sperm production and male fertility. This ope...pill" for men. The discovery also offers hope to t...
(Date:11/26/2009)... , Prized for their impressive antlers, red deer ...tions. But a deer,s antlers are much more than dec...together when duelling. John Currey, from The Univ...anical properties of bone for over half a century ...ties of antler through a long-standing collaborati...
(Date:11/26/2009)... , , Heidelberg, 27 November 2009 What are the...ients required to produce a cell that can survive ...of a cell, and understand how an entire organism f...uestions that scientists in a partnership between ...n Heidelberg, Germany, and the Centre de Regulacio...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3PriceSpective Continues Global Expansion With New San Diego Office 13900 1PriceSpective Continues Global Expansion With New San Diego Office 13900 2Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 1Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 2Fabricating 26 Metalworkings Riley Takes Congress to Task on Cap and Trade 56388 3PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately 2471 Million 13897 1PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately 2471 Million 13897 2PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately 2471 Million 13897 3
...at originally enhanced robotics and sounding rocke...seas duty with spinal cord or traumatic brain inju...gton, D.C. The revolutionary new physical therapy ...is based on technology originally developed and ho...belt, Md. , The late James Kerley created and pa...
... production of a potent immune regulator called in...ler (NK) cells, immune cells that typically defend...produced by NK cells and other cell types, plays a...and in defending against tumor cells. However, ove...and can cause autoimmune diseases. But exactly how...
...s traditionally not associated with foodborne dise...though rare. Public health officials should be aw...ts presenting today at the 106th General Meeting o...rlando, Florida. "The more we find out about the b...dous foods the more we are beginning to understand...
Other Biology News:NASA technology helping injured US troops 2NASA technology helping injured US troops 3Research reveals control of potent immune regulator 2Despite acidity, orange juice could still be a source of foodborne disease 2
Rabbit Anti-Uncoupling Protein-2, aa 144-157 Polyclonal Antibody, Unconjugated from Calbiochem
...n translation initiation. PHAS-II is highest in li...mRNA cap-binding protein, and inhibit translation ...ion in the appropriate site(s) promotes dissociati... bind to eIF-4G (p220), thereby increasing the amo...
Human GCP-2, Unconjugated from CHEMICON
Corning Culture Flask, 150 cm2, Tc-Treated, Angled Neck, Phenolic-Style, Sterile from Sigma-Aldrich
Biology Products: